Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Hanratty

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
JMIR Research Protocols|March 26, 2019
Using Values Affirmation to Reduce the Effects of Stereotype Threat on Hypertension Disparities: Protocol for the Multicenter Randomized Hypertension and Values (HYVALUE) TrialStacie L Daugherty, Suma Vupputuri, Rebecca Hanratty, et al.
JAMA Network Open|December 16, 2021
Effect of Values Affirmation on Reducing Racial Differences in Adherence to Hypertension Medication: The HYVALUE Randomized Clinical TrialStacie L Daugherty, Laura Helmkamp, Suma Vupputuri, et al.
Journal of General Internal Medicine|February 20, 2014
An investigation of associations between clinicians' ethnic or racial bias and hypertension treatment, medication adherence and blood pressure controlIrene V Blair, John F Steiner, Rebecca Hanratty, et al.
Journal of General Internal Medicine|February 8, 2022
Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic TrialIngrid A Binswanger, Deborah Rinehart, Shane R Mueller, et al.
Journal of Electrocardiology|March 18, 2008
Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiographyEdward P Havranek, Caroline D B Emsermann, Desiree N Froshaug, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 6, 2009
Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertensionRebecca Hanratty, Michel Chonchol, L Miriam Dickinson, et al.
Patient Preference and Adherence|March 30, 2023
Patient Pill Organization Strategies and Adherence Measured in a Cross-Sectional Study of HypertensionMatthew P Genelin, Laura J Helmkamp, John F Steiner, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2022
Relationship Between Social Vulnerability Indicators and Trial Participant Attrition: Findings From the HYVALUE TrialKamal H Henderson, Laura J Helmkamp, John F Steiner, et al.
Annals of Family Medicine|January 16, 2013
Clinicians' implicit ethnic/racial bias and perceptions of care among Black and Latino patientsIrene V Blair, John F Steiner, Diane L Fairclough, et al.
Addiction Science & Clinical Practice|June 7, 2024
Using 42 CFR part 2 revisions to integrate substance use disorder treatment information into electronic health records at a safety net health systemAlexandra R Tillman, Emily Bacon, Brooke Bender, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JMIR Research Protocols|March 26, 2019
Using Values Affirmation to Reduce the Effects of Stereotype Threat on Hypertension Disparities: Protocol for the Multicenter Randomized Hypertension and Values (HYVALUE) TrialStacie L Daugherty, Suma Vupputuri, Rebecca Hanratty, et al.
JAMA Network Open|December 16, 2021
Effect of Values Affirmation on Reducing Racial Differences in Adherence to Hypertension Medication: The HYVALUE Randomized Clinical TrialStacie L Daugherty, Laura Helmkamp, Suma Vupputuri, et al.
Journal of General Internal Medicine|February 20, 2014
An investigation of associations between clinicians' ethnic or racial bias and hypertension treatment, medication adherence and blood pressure controlIrene V Blair, John F Steiner, Rebecca Hanratty, et al.
Journal of General Internal Medicine|February 8, 2022
Naloxone Co-Dispensing with Opioids: a Cluster Randomized Pragmatic TrialIngrid A Binswanger, Deborah Rinehart, Shane R Mueller, et al.
Journal of Electrocardiology|March 18, 2008
Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiographyEdward P Havranek, Caroline D B Emsermann, Desiree N Froshaug, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 6, 2009
Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertensionRebecca Hanratty, Michel Chonchol, L Miriam Dickinson, et al.
Patient Preference and Adherence|March 30, 2023
Patient Pill Organization Strategies and Adherence Measured in a Cross-Sectional Study of HypertensionMatthew P Genelin, Laura J Helmkamp, John F Steiner, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2022
Relationship Between Social Vulnerability Indicators and Trial Participant Attrition: Findings From the HYVALUE TrialKamal H Henderson, Laura J Helmkamp, John F Steiner, et al.
Annals of Family Medicine|January 16, 2013
Clinicians' implicit ethnic/racial bias and perceptions of care among Black and Latino patientsIrene V Blair, John F Steiner, Diane L Fairclough, et al.
Addiction Science & Clinical Practice|June 7, 2024
Using 42 CFR part 2 revisions to integrate substance use disorder treatment information into electronic health records at a safety net health systemAlexandra R Tillman, Emily Bacon, Brooke Bender, et al.
Pageof 4